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been documented in multicenter, randomized, controlled
trials.1-6 However, CEA is not perfect, and there remains
room for improvement. Complications related to CEA
include perioperative myocardial infarction, stroke, cranial
nerve injury, and wound problems that have been reported
at cumulatives rates ranging between 12% and 21%.1-6 In
addition, there are certain groups of patients who are
deemed high risk for CEA. These patients include those
with severe comorbid conditions such as unstable angina or
a hostile neck resulting from previous surgery (including
CEA), radical neck dissection with or without radiation
therapy, and the presence of a tracheostomy.7
Carotid artery stenting (CAS) has recently emerged as
an alternative to CEA. Although good results have been
reported from several centers,8-15 concerns regarding the
safety and efficacy of CAS have been raised, and its general
role and comparative value remain unclear.16-22 One of
the major concerns has been the potential for CAS to pro-
duce embolic particles that may manifest as a neurologic
deficit.17,18,23 Several devices have recently been devel-
oped that can capture these embolic particles, thus reduc-
Stroke is the third leading cause of death in the United
States, with 1.5 deaths reported per 1000 persons. Carotid
endarterectomy (CEA) is considered to be the gold stan-
dard treatment to reduce the risk of stroke in patients with
significant carotid artery occlusive disease, and this has
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Objective: The role of percutaneous angioplasty and stenting of carotid bifurcation lesions has been limited by its poten-
tial for producing embolic debris. We evaluated the efficacy of a proximal occlusion catheter (POC) in the prevention
of embolic events during carotid artery stenting. In addition, pressure measurements relevant to the clinical application
of this device were obtained from 10 patients undergoing carotid endarterectomy. 
Methods: The POC is a guiding catheter with an occlusion balloon attached on the outside of the catheter at its distal
end. Occlusion of the common carotid artery (CCA) was achieved by inflating the balloon while access to carotid bifur-
cation lesions was obtained through the inner lumen. The POC was inserted in the CCA of 10 dogs via the femoral
artery. The side port of the POC was connected to a sheath placed in the femoral vein, thereby creating an external
arteriovenous shunt. Ten artificial radiopaque particles simulating embolic particles and contrast agent were introduced
in the CCA and monitored fluoroscopically. As a control, the same procedure was performed with a standard guiding
catheter without an occlusion balloon. In 10 patients undergoing carotid endarterectomy, the internal carotid artery
(ICA) and external carotid artery stump pressures and the pressure in the internal jugular vein were measured.
Results: Without the external arteriovenous shunt, in all animals there was prograde flow in the distal CCA despite CCA
occlusion. This flow was derived from the thyroid artery. However, once the arteriovenous shunt was activated, rever-
sal of flow in the distal CCA was achieved in each animal, and all the artificial particles were recovered from the side
port of the POC. In the control group, each particle embolized to the brain (100%, P < .01). In the patients, the mean
stump pressures in the ICA and external carotid artery and the jugular vein pressure were 51.8 ± 14.2, 62.2 ± 15.1,
and 6.5 ± 3.5 mm Hg, respectively. In each case, the jugular vein pressure was the lowest among the three. 
Conclusions: Obtaining proximal CCA control by inflating the POC does not sufficiently prevent embolization.
However, reversal of flow in the ICA can always be created with the external shunt, which effectively prevents
embolization. Thus, POC may markedly lower procedural stroke rates during carotid artery stenting. The ability of
POC to prevent embolization before crossing the lesion with a guidewire may be an important advantage over other
distal protection devices. (J Vasc Surg 2001;33:504-9.)
ing perioperative complications.15,24,25 The current study
was undertaken to determine the feasibility and efficacy of
a novel proximal occlusion catheter in the prevention of
embolic events during CAS with a canine model.
MATERIALS AND METHODS
The Parodi Anti-Embolization Catheter. The
Parodi Anti-Embolization Catheter (PAEC) (ArteriA, Inc,
San Francisco, Calif) is a triple lumen-guiding catheter
with an occlusion balloon attached to the outside of the
catheter at the distal end. This balloon has a teardrop
shape so that there will be no dead space between the ori-
fice of the catheter and the occlusion balloon (Fig 1).
Occlusion of the common carotid artery (CCA) is
achieved by inflating this balloon while maintaining access
to the carotid lesion through the main inner lumen. The
guide catheter is equipped with a dilator that permits its
safe, smooth insertion into the CCA over a wire. The main
lumen has an inner diameter of 7F that allows the passage
of balloons and stents. The main lumen is connected to a
three-way Y-adapter at its proximal end so that one has
access to the lesion through the main lumen while suction
is applied or reversal of flow is created through the other
ports (Fig 1). In addition, the extra side port can be used
for the insertion of an external carotid artery (ECA) occlu-
sion balloon, if needed. 
Canine study. Under Institutional Animal Care and
Use Committee approval, 10 greyhound dogs that
weighed 30 to 40 kg were used. An intravenous line was
placed in a forefoot vein for intravascular access and fluid
administration. The dogs were anesthetized with intra-
venous thiopental (7 mg/kg body weight) induction and
butorphanol (0.2 mg/kg) analgesia and were maintained
with thiopental continuous drip at 4 mg/kg per hour
given with normosol fluids running at 10 mL/kg per
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hour. Endotracheal intubation was performed, and a
Harvard pump ventilator was used as needed. A pulse
oximeter monitored pulse rate and oxygen saturation. 
Percutaneous access to both femoral arteries was
obtained with the Seldinger technique. After a 10F sheath
was placed in one femoral artery, the animals were system-
ically heparinized (1 mg/kg body weight). Under fluoro-
scopic control, a 0.038-in guidewire (Glidewire; Meditech,
Oakland, NJ) was used to access the CCA. The PAEC was
introduced over the guidewire and placed in the proximal
CCA under fluoroscopic guidance. Contrast was injected
through the main lumen of the PAEC, and a baseline cer-
vical and intracranial carotid angiogram was obtained. The
location of the thyroid artery was identified (Fig 2, A).
The tip of the PAEC was placed within the CCA 3 to 5 cm
below the thyroid artery. The occlusion balloon attached
at the tip of the PAEC was then inflated to occlude flow
in the CCA. On the basis of the previous angiogram, the
occlusion balloon was inflated to the size of the CCA. The
side port of the PAEC was connected to a sheath placed in
the femoral vein to create a temporary arteriovenous shunt
(Fig 3).
An angioplasty balloon (4 mm × 2 cm, Savvy; Cordis,
Warren, NJ) was then inserted in the CCA. Its distal end
was placed at the level of the thyroid artery. 
Experiment 1. Three milliliters of contrast material
was injected through the central lumen of the angioplasty
balloon, and the trajectory of the contrast was monitored
Fig 1. The PAEC (7F sheath) has an elastic teardrop-shaped bal-
loon (inset) attached at its distal end. The balloon can be inflated
through one of the side ports (I). The Y-adapter allows insertion
of several devices, including Parodi External Balloon, and permits
connection to sheath inserted in femoral vein, thereby creating
arteriovenous fistula and reversal of flow.
Fig 2. A, Angiogram of CCA before inflation of PAEC. The thy-
roid artery is visualized (T ). Arrows denote direction of blood
flow in each vessel. B, Angiographic image of CCA after inflation
of PAEC (X) but without activation of arteriovenous fistula and
reversal of flow. Contrast was injected from tip of angioplasty bal-
loon at the level of the thyroid artery. The thyroid artery is giving
rise to prograde flow in distal CCA. Arrows denote direction of
blood flow in each vessel. C, Angiographic image of CCA with
PAEC occlusion and activation of arteriovenous fistula. Flow in
distal common and thyroid arteries is reversed, and contrast
injected through tip of angioplasty balloon is now flowing toward
PAEC. D, Metallic particles and contrast material are being
recovered with reversal of flow. P, Inflated balloon at tip of PAEC.
with continuous fluoroscopy. The injection was performed
with and without establishment of the arteriovenous shunt.
Experiment 2. Ten metallic particles (1.0 mm in
diameter) were introduced into the CCA distal to the
occlusion balloon through the main channel of the PAEC.
The PAEC was then used to recover the metallic particles.
The trajectory and end point of the particles were moni-
tored with continuous fluoroscopy. The number of parti-
cles recovered and the number of particles present in the
brain on x-ray film were counted. In the control group,
the particles were released into the carotid artery with a
standard 9F guiding catheter. On completion of the exper-
iment, the animals were humanely killed.
Clinical investigation. Pressure measurements rele-
vant to the clinical application of the PAEC were obtained
from 10 consecutive patients undergoing CEA. None of
these patients had contralateral carotid artery occlusion.
The stump pressures (back pressure) of the internal
carotid artery (ICA) and the ECA were measured by plac-
ing a 21-gauge needle in the distal CCA after the carotid
bifurcation was completely dissected from the surround-
ing tissue. The pressure was measured with a standard
pressure transducer. The ICA stump pressure was mea-
sured by clamping the CCA and the ECA, whereas the
ECA stump pressure was measured by clamping the ICA
and the CCA. 
RESULTS
In all 10 animals, the flexible PAEC satisfactorily
tracked the guidewire previously placed in the CCA, and
placement of the PAEC into the CCA was accomplished
without difficulty. Of note is the fact that the PAEC was
very stable throughout the procedure and no movement
of the catheter or the balloon was observed.
Experiment 1. Without the external arteriovenous
shunt, there was prograde flow in the distal CCA despite
proximal CCA occlusion with the PAEC, and the injected
contrast flowed toward the brain in each animal (Fig 2, B).
This flow was derived from the thyroid artery. However,
once the temporary arteriovenous shunt was established,
reversal of flow in the carotid artery as well as in the thy-
roid artery occurred in each animal, and the injected con-
trast material flowed toward the PAEC and ultimately into
the femoral vein (Fig 2, C).
Experiment 2. The metallic particles were introduced
into the CCA in both the PAEC group and in the control
group. In the PAEC group, none of the particles intro-
duced flowed to the brain, and each was recovered from
the side port of the PAEC (Fig 2, D). On the other hand,
all of the particles introduced into the control animals
flowed upstream and embolized to the brain. The differ-
ence between the two groups was statistically significant
(paired t test, P < .001). All of the study animals main-
tained arteriovenous flow from the carotid artery to the
femoral vein throughout the experiment.
Clinical investigation. The mean stump pressures of
the ICA and the ECA and the jugular vein pressure mea-
sured in patients were 51.8 ± 14.2, 62.2 ± 15.1, and 6.5
± 3.5 mm Hg, respectively. The jugular vein pressure was
significantly lower than in both the ICA and the ECA. In
each case, the jugular vein pressure was the lowest among
the three.
DISCUSSION
Although several researchers have reported satisfactory
results after CAS and have advocated the widespread use
of this technology, CAS has not gained popularity.8-11,26
Among the various reasons for this is the risk of emboliza-
tion.17,18,23
The potential for embolization was demonstrated in
our previous work, in which human carotid artery speci-
JOURNAL OF VASCULAR SURGERY
506 Ohki et al March 2001
Fig 3. Groin access sites in the animal. The PAEC (P) has been
inserted into CCA through a 10F sheath placed in the femoral
artery. Reversal of flow is achieved by activating the shunt (S).
The shunt connects the side port of PAEC and sheath (V )
inserted in the femoral vein.
Fig 4. A, Direction of blood flow with proximal CCA occlusion
only. Because ECA pressure is higher than that of ICA in most
cases, prograde flow in ICA will be maintained via ECA despite
inflow control. B, Because femoral vein pressure is significantly
lower than both ICA and ECA pressures, reversal of flow in both
carotid arteries can be obtained by activating arteriovenous shunt. 
A B
mens obtained from patients undergoing standard CEA
procedures were used.23 CAS was performed in an in vitro
model, and the embolic materials generated were ana-
lyzed. In that study, we demonstrated that embolic mate-
rials were produced from each plaque that was stented.
This observation was confirmed by several clinical investi-
gations in which the embolic events during CEA and CAS
were analyzed with a transcranial Doppler scan.27-29
On the basis of these observations, it is clear that CAS
without some form of protection carries a higher risk of
embolization compared with CEA. For this devastating
complication associated with CAS to be overcome, several
devices have been developed in an effort to capture these
embolic particles and reduce neurologic events.
There are three distinctively different approaches to
cerebral protection. These include distal occlusion balloons,
distal filtration devices, and proximal occlusion catheters.
Each approach possesses unique strengths and weaknesses.
The chief disadvantages of any form of distal protec-
tion device are the need to cross the lesion with the device
and the possibility of cerebral microembolization before
cerebral protection is achieved.30,31 Coggia et al30 recently
studied the relationships among the emboli generated
during each step of the endovascular procedure in an ex
vivo model with human carotid specimens. In this study,
the number of microemboli generated was evenly distrib-
uted throughout each step of the intervention, including
initial guidewire passage, balloon dilatation, and stent
placement. In addition, because all filtration devices have
pores to allow the blood to flow, they also have the poten-
tial for allowing particles smaller than the pore size to pass
through the filter.31 There is experimental and clinical evi-
dence in the literature that shows the significance of these
small particles on cerebral ischemia.32-34 In addition, it 
has been reported that thrombus and fragile material are
present on the luminal surface of 30% to 60% of plaques
obtained from CEAs.35,36 Therefore, the potential for
small particles to be released and the consequences cannot
be underestimated. We think that the ability of the PAEC
to achieve cerebral protection before crossing the lesion
and the fact that particles of all sizes can be captured are
major advantages over protection devices that are placed
distal to the lesion. 
The fact that the PAEC does not need to cross the
lesion to provide protection is especially valuable when
plaques associated with a tight stenosis or with a tortuous
ICA, which is not uncommon in patients undergoing CAS,
are being treated. Although they may vary from one device
to another, all distal protection devices have larger crossing
profiles and are less flexible than a standard coronary
guidewire that is otherwise used. Because of this added
crossing profile and stiffness, difficulties in crossing tight
stenoses and tortuous vessels have been encountered with
distal protection devices. Because the PAEC can achieve
protection without crossing the lesion, the characteristics
of the lesion and the distal vasculature become irrelevant. 
Another advantage of the PAEC is related to the rela-
tive ease and simplicity of its use. The use of either a guid-
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ing catheter or a long sheath is a prerequisite in performing
CAS. The PAEC is essentially a long sheath with a balloon
attached at the distal end. Once the balloon is inflated and
the flow in the ICA, ECA, and CCA is reversed, then one
can perform CAS under brain protection in a standard man-
ner with standard devices. Any form of distal protection
device will be anchored to the distal ICA to achieve a water-
tight seal between the balloon and the outer edge of the fil-
ter. Therefore, any motion of the distal protection device
and the guidewire can potentially cause vessel spasm or dis-
section. Although the PAEC can also cause spasm in the
CCA, such a complication is easier to treat than spasm or
dissection occurring in the distal ICA. 
The fact that the use of the PAEC does not preclude
the simultaneous use of other distal protection devices
may also be considered a strength. It is conceivable that in
some cases, the PAEC could not establish reversal of flow
and cerebral protection. In such an instance, one can use
the PAEC as a standard guiding catheter and proceed with
CAS with or without other means of distal protection. 
A potential disadvantage of the PAEC is that it inter-
rupts prograde cerebral flow. However, we think that most
patients tolerate carotid occlusion and that they will toler-
ate the use of such a device. The surgical literature on the
risk of clamping the carotid artery and the benefit of tem-
porary shunting gives us some insight into this issue.
Perioperative neurologic deficits after CEA may be attrib-
utable to factors other than clamping intolerance, such as
microembolization.37 In a series of 140 CEAs without
shunting, Moreau and Bonnaure38 found that only 2.1% of
patients did not tolerate clamping and demonstrated neu-
rologic deficits. Furthermore, technical errors appeared to
be responsible for more strokes than clamp intolerance.
Lawrence et al,39 in a series of 200 patients with CEAs per-
formed with patients under regional anesthesia without a
shunt, demonstrated that only 2% of these patients had
cerebral ischemia. Finally, Hussain et al,40 in a series of 573
CEAs, found that there was no difference in outcome
between those who had shunts and those who did not, and
they contend that intraoperative interruption of the carotid
flow did not affect morbidity and mortality rates. To pre-
vent prograde flow in the ICA and to prevent emboliza-
tion, one only needs to create a minimal amount of reversal
of flow with the PAEC. However, even though the rever-
sal of the flow is kept to a minimum, it is not equivalent to
a simple occlusion of the carotid artery, such as that per-
formed during surgery, and therefore, the aforementioned
surgical experience may not directly apply to the PAEC. 
Patients with contralateral ICA occlusion might be
considered by some to be unsuitable for the PAEC; how-
ever, we think that the majority of such patients will toler-
ate proximal occlusion and be candidates for the PAEC.
For example, Samson et al41 demonstrated that in CEAs
performed without a shunt in 1513 patients with con-
tralateral lesions ranging from 79% stenosis to complete
occlusion, the immediate postoperative stroke rate was
only 0.76%. They concluded that CEA can be safely per-
formed without a shunt even in the presence of a con-
tralateral occlusion. This observation has also been con-
firmed through our experience.42 If the intolerance to
ischemia is a concern, a preoperative cerebral angiogram
can be used to predict with certainty which patients will
tolerate occlusion with the PAEC by evaluating the pres-
ence or absence of anterior and posterior communicating
arteries, because cerebral angiograms can predict with low
false-negative and false-positive rates which patients will
require shunt placement during CEA.42,43
The concept of proximal occlusion is not unique to
the PAEC and has been previously described by Kachel44
(Fig 4). However, proximal occlusion alone was insuffi-
cient to prevent particles from embolizing to the brain
because of collateral vessels such as the ECA, giving rise to
prograde flow in the ICA.45 This was also confirmed in
the current study in which the contrast was injected after
PAEC occlusion with and without reversal of flow. In all
animals, the thyroid artery gave sufficient prograde flow to
the carotid artery to carry the contrast toward the brain.
With activation of the arteriovenous fistula, reversal of
flow in both the carotid and thyroid arteries was achieved
in all animals, because the pressure in the femoral vein was
the lowest among all the vessels involved. This will be the
case in most if not all patients on the basis of our small
clinical investigation in which we measured the stump
pressures of the ICA and ECA and the pressure in the
jugular vein, which we assumed to be equivalent to the
pressure in the femoral vein. The pressure difference
between the two arterial stump pressures and the venous
pressure was such that one can assume that sufficient
reversal of flow can be achieved in patients, also. The
observation by Archie46 regarding the difference in arte-
rial stump pressure and the venous pressure also supports
our hypothesis. If reversal of flow cannot be achieved, an
alternative method will be the use of the Parodi External
Balloon (ArteriA) to occlude the ECA.31 With the Parodi
External Balloon, complete protection can be achieved
without reversal of flow. 
Because the current study was performed in dogs
without carotid lesions, the true value of the PAEC in the
prevention of distal embolization must be evaluated in
clinical trials. In addition, because the anatomy of the
carotid artery in the canine model used in this model is
different from that of the human carotid artery in that the
thyroid artery takes off directory from the CCA in
canines, the results obtained in this study need to be inter-
preted carefully and do not ensure the efficacy of the
PAEC in humans. However, early clinical experience has
been promising. Parodi31 has performed 20 CASs under
PAEC protection. Thus far, technical success was achieved
in all cases, and every patient tolerated the proximal occlu-
sion. There have been no perioperative ischemic neuro-
logic complications. 
The PAEC may also be able to prevent embolic events
during endovascular procedures performed in other
lesions, such as those in coronary arteries, saphenous vein
graft lesions, and long iliac and superficial femoral artery
occlusions, with the same principle of inflow control and
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reversal of flow. In addition, because CEA is also associated
with the release of emboli, especially during the initial dis-
section phase before arterial control is obtained, there may
be a role for applying the PAEC and reversing the flow in
the carotid arteries during CEA until one obtains arterial
control by means of surgical clamping.33,37,47
If the PAEC proves to be effective in retrieving parti-
cles and reducing the stroke rate associated with CAS
without significantly adding to the complexity of the pro-
cedure itself, it may resolve the major issue that is pre-
venting widespread acceptance of CAS. The ability of the
PAEC to prevent embolization before crossing the lesion
with a guidewire may be an important advantage over
other distal protection devices.
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